Sorry, registration has ended.

Faculty: Edwin Waldbusser ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ |‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ Code: FDB3399


  • Date:5/2/2023 11:00 AM - 5/2/2023 12:00 PM
  • Time zone: Eastern Time (US/Canada) Online Event

Description

In this webinar you will learn about the types of FDA inspections, preparations such as assigning dedicated personnel to specific tasks for the inspection, facility requirements to support the inspection ( front room, back room), the value of mock audits, how personnel should conduct themselves, the inspection process and how to respond to 483s and warning letters.

FDA is required to conduct an inspection every two years. A company that is prepared for the inspection is less likely to receive 483’s than a disorganized company. If a 483 is received knowing how to respond will lessen chances of receiving a Warning Letter.

Areas Covered in the Session :

  • Personnel Preparation
  • Facility Needed to Support Inspection
  • Behavior During Inspection-what not to Sign
  • Internal/ Mock Audits
  • 483 Response

Who Should Attend:

  • Quality Departments
  • Regulatory Affairs Departments
  • Manufacturing Departments
  • Engineering Departments
  • Corporate Management
  • Division Management

Course Director: Edwin Waldbusser

 

Edwin Waldbusser retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. He was involved in the development of products such as IVD devices, kidney dialysis systems and inhalation devices. His QS experience includes, design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing/non-conforming product programs. He now consults in the area of quality systems for medical devices with emphasis on design control, software validation, risk analysis and human factors analysis.

Ed has a B.S. Mechanical Engineering from NYU and a M.B.A from Drexel University. He is certified by Lloyds of London as an ISO 9000 Lead Auditor and is a member of the Thomson Reuters Expert Witness network. He has 5 issued patents.